MBX Biosciences, Inc. insider trading

By person

23 insiders · 39 transactions

104×

P. Kent Hawryluk holds 104 times base salary in stock. $65.53M of shares against $625.00K in salary for 2025.

Salary from the company's own proxy. The shares are what P. Kent Hawryluk last reported holding, valued at $53.96, the price Common Stock was last bought or sold at on the open market here, on 4 Nov 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Patrick J Heron

Director

$22.00M (2)

—

+$22.00M

5,219,440

10.84%

$281.64M

—

Carl L Gordon

Director

$14.02M (6)

—

+$14.02M

747,887

1.55%

$40.36M

—

Orbimed Advisors LLC entity

Director

$14.02M (6)

—

+$14.02M

747,887

1.55%

$40.36M

—

Tiba Aynechi

Director

$12.00M (1)

—

+$12.00M

2,136,335

4.44%

$115.28M

—

Frazier Life Sciences X, L.P.

10% owner

$10.00M (1)

—

+$10.00M

4,552,774

9.45%

$245.67M

—

Forest Baskett

10% owner

$8.00M (1)

—

+$8.00M

3,614,486

7.51%

$195.04M

—

Ali Behbahani

10% owner

$8.00M (1)

—

+$8.00M

3,614,486

7.51%

$195.04M

—

Carmen Chang

10% owner

$8.00M (1)

—

+$8.00M

3,614,486

7.51%

$195.04M

—

Anthony A. Florence Jr.

10% owner

$8.00M (1)

—

+$8.00M

3,614,486

7.51%

$195.04M

—

Mohamad Makhzoumi

10% owner

$8.00M (1)

—

+$8.00M

3,614,486

7.51%

$195.04M

—

Edward T Mathers

Director

$8.00M (1)

—

+$8.00M

3,614,486

7.51%

$195.04M

—

New Enterprise Associates 17, L.P. entity

10% owner

$8.00M (1)

—

+$8.00M

3,614,486

7.51%

$195.04M

—

Scott D Sandell

10% owner

$8.00M (1)

—

+$8.00M

3,614,486

7.51%

$195.04M

—

Paul Edward Walker

10% owner

$8.00M (1)

—

+$8.00M

3,614,486

7.51%

$195.04M

—

Rick Yang

10% owner

$8.00M (1)

—

+$8.00M

3,614,486

7.51%

$195.04M

—

Salomon Azoulay

Chief Medical Officer

—

$2.74M (5) scheduled

−$2.74M

14,026

0.0291%

$756.84K

—

P. Kent Hawryluk

President & CEO

$1.33M (3)

$17.93K (1)

+$1.32M

1,214,444

2.52%

$65.53M

+153.1%

Steven L. Hoerter

President and CEO

$264.98K (1)

—

+$264.98K

102,938

0.2137%

$5.55M

—

Ora H. Pescovitz

Director

$45.31K (1)

—

+$45.31K

24,329

0.0505%

$1.31M

+46.2%

Wellington Biomedical Innovation Master Investors (Cayman) II L.P.

10% owner

—

1,790,122

3.72%

$96.59M

—

James M Cornelius

Director

—

102,082

0.2120%

$5.51M

—

John W Smither

Chief Financial Officer

—

28,000

0.0581%

$1.51M

—

Richard Bartram

Chief Financial Officer

—

15,000

0.0311%

$809.40K

—

MBX Biosciences, Inc.

What the insiders did Net buying

By person